ABDXF Stock: Abingdon Health Plc Stock Price, Analysis & Insights
Get live abdxf stock price $0.07, comprehensive Abingdon Health Plc stock analysis, charts, news, and expert forecast. Real-time abdxf stock data and investment insights.
Company Overview
Abingdon Health Plc engages in the development, manufacture, and distribution of diagnostic devices worldwide. The company offers AbC-19 Rapid Test, a COVID-19 IgG rapid antibody test; nucleic acid lateral flow immunoassays; PCRD and PCRD FLEX, nucleic acid lateral flow tests used for rapid readouts post isothermal amplification; Abingdon Simply Test, a range of self-tests; and 2019-nCoV Antigen Test, a rapid lateral flow test for the qualitative detection of antigens to SARS-CoV-2. It also provides AppDx, a customizable image capturing technology that transforms a smartphone into a self-sufficient and standalone lateral-flow reader. In addition, the company provides contract manufacturing, nucleic acid lateral flow test customization, and lateral flow development and manufacturing services. Further, it provides consultancy services to businesses in the healthcare technology sector. The company has a collaboration and co-marketing agreement with Abcam plc. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.
Company Information
- CEO
- Christopher William Hand
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 113
Contact Information
- Address
- York Biotech Campus
- Country
- GB
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 13.27M market capitalization
- Trading Volume: 10.00K shares traded today
- Price Range: 52-week range of $0.07 - $0.07
- Exchange: Listed on Other OTC
Financial Metrics
Market Analysis for Abingdon Health Plc
Abingdon Health Plc (ABDXF) operates in the Medical - Diagnostics & Research industry within the Healthcare sector. With a current market capitalization of 13.27M, the company represents a significant player in its market. The stock is currently trading at $0.07 with a positivedaily change of 0.00%.
The company's 113 employee base and presence on the Other OTCexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -1.40, beta of 0.18, and 52-week price range from $0.07 to $0.07when evaluating investment opportunities.
Why Invest in Abingdon Health Plc?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (Other OTC)
- • Experienced leadership under Christopher William Hand
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.